TY - JOUR A1 - Kohmer, Niko A1 - Toptan, Tuna A1 - Pallas, Christiane A1 - Karaca, Onur A1 - Pfeiffer, Annika Eby A1 - Westhaus, Sandra A1 - Widera, Marek A1 - Berger, Annemarie A1 - Hoehl, Sebastian A1 - Kammel, Martin A1 - Ciesek, Sandra A1 - Rabenau, Holger T1 - The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro T2 - Journal of clinical medicine N2 - Due to globally rising numbers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, resources for real-time reverse-transcription polymerase chain reaction (rRT-PCR)-based testing have been exhausted. In order to meet the demands of testing and reduce transmission, SARS-CoV-2 antigen-detecting rapid diagnostic tests (Ag-RDTs) are being considered. These tests are fast, inexpensive, and simple to use, but whether they detect potentially infectious cases has not been well studied. We evaluated three lateral flow assays (RIDA®QUICK SARS-CoV-2 Antigen (R-Biopharm), SARS-CoV-2 Rapid Antigen Test (Roche)), and NADAL® COVID-19 Ag Test (Nal von Minden GmbH, Regensburg, Germany) and one microfluidic immunofluorescence assay (SARS-CoV-2 Ag Test (LumiraDx GmbH, Cologne, Germany)) using 100 clinical samples. Diagnostic rRT-PCR and cell culture testing as a marker for infectivity were performed in parallel. The overall Ag-RDT sensitivity for rRT-PCR-positive samples ranged from 24.3% to 50%. However, for samples with a viral load of more than 6 log10 RNA copies/mL (22/100), typically seen in infectious individuals, Ag-RDT positivity was between 81.8% and 100%. Only 51.6% (33/64) of the rRT-PCR-positive samples were infectious in cell culture. In contrast, three Ag-RDTs demonstrated a more significant correlation with cell culture infectivity (61.8–82.4%). Our findings suggest that large-scale SARS-CoV-2 Ag-RDT-based testing can be considered for detecting potentially infective individuals and reducing the virus spread. KW - SARS-CoV-2 KW - POCT KW - Ag-RDT KW - PCR KW - cell culture KW - infectivity Y1 - 2021 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/59365 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-593653 SN - 2077-0383 N1 - Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). VL - 10 IS - 2, art. 328 SP - 1 EP - 11 PB - MDPI CY - Basel ER -